Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

PI3Ki's in Indolent Lymphoma: Overview of Approved Drugs, Trial Based Data on Toxicity and Efficacy of Upcoming PI3Ki's, and the Pre-Clinical Rationale of PI3Ki's+Targeted

0 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login